oxatomide has been researched along with (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tschopp, JM; Turner-Warwick, M | 1 |
| Charlton, J; D'Souza, MF; Emanuel, MB; Goldschmidt, J; Gregg, J | 1 |
1 trial(s) available for oxatomide and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
| Article | Year |
|---|---|
A method for evaluating therapy for hay fever. A comparison of four treatments.
Topics: Adult; Airway Resistance; Beclomethasone; Clinical Trials as Topic; Cromolyn Sodium; Female; Forced Expiratory Volume; Humans; Male; Patient Compliance; Piperazines; Placebos; Pollen; Rhinitis, Allergic, Seasonal; Self-Assessment | 1983 |
1 other study(ies) available for oxatomide and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
| Article | Year |
|---|---|
Persisting airflow limitation in asthmatics receiving routine self-adjusted medication.
Topics: Adult; Aerosols; Age Factors; Albuterol; Asthma; Beclomethasone; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Peak Expiratory Flow Rate; Piperazines; Pulmonary Ventilation; Respiratory Therapy; Spirometry; Time Factors | 1984 |